Wall Street brokerages forecast that LHC Group (NASDAQ:LHCG) will report $0.60 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for LHC Group’s earnings. The lowest EPS estimate is $0.57 and the highest is $0.65. LHC Group reported earnings per share of $0.54 in the same quarter last year, which suggests a positive year over year growth rate of 11.1%. The firm is scheduled to issue its next quarterly earnings results before the market opens on Monday, November 6th.

According to Zacks, analysts expect that LHC Group will report full-year earnings of $2.40 per share for the current fiscal year, with EPS estimates ranging from $2.36 to $2.50. For the next financial year, analysts expect that the firm will report earnings of $2.64 per share, with EPS estimates ranging from $2.60 to $2.75. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for LHC Group.

LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The business had revenue of $260.20 million for the quarter, compared to analyst estimates of $254.10 million. During the same period last year, the business posted $0.52 EPS. LHC Group’s revenue was up 15.1% compared to the same quarter last year.

LHCG has been the topic of several analyst reports. Royal Bank Of Canada reaffirmed a “buy” rating and set a $70.00 price target on shares of LHC Group in a research report on Wednesday, September 6th. Bank of America Corporation initiated coverage on shares of LHC Group in a research report on Monday, August 21st. They set a “buy” rating and a $76.00 price target on the stock. BidaskClub raised shares of LHC Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Jefferies Group LLC reaffirmed a “buy” rating and set a $68.00 price target on shares of LHC Group in a research report on Friday, August 4th. Finally, Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price target on the stock in a research report on Saturday, August 5th. Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $66.60.

LHC Group (NASDAQ:LHCG) traded down 0.38% on Tuesday, reaching $67.57. 25,862 shares of the company were exchanged. The firm has a market capitalization of $1.24 billion, a PE ratio of 29.90 and a beta of 0.76. LHC Group has a 12-month low of $32.04 and a 12-month high of $73.85. The stock has a 50 day moving average of $66.96 and a 200 day moving average of $62.90.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the stock in a transaction that occurred on Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the sale, the chief operating officer now owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 14.80% of the stock is owned by company insiders.

Hedge funds have recently made changes to their positions in the company. Federated Investors Inc. PA grew its position in shares of LHC Group by 4.2% during the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock worth $110,000 after buying an additional 66 shares during the period. Acrospire Investment Management LLC grew its position in LHC Group by 30.8% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after purchasing an additional 400 shares during the period. Cubist Systematic Strategies LLC grew its position in LHC Group by 758.0% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock valued at $116,000 after purchasing an additional 1,516 shares during the period. Invictus RG acquired a new stake in LHC Group in the 1st quarter valued at $125,000. Finally, First Mercantile Trust Co. acquired a new stake in LHC Group in the 2nd quarter valued at $147,000. 87.24% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This story was first reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/10/24/zacks-brokerages-expect-lhc-group-lhcg-will-post-earnings-of-0-60-per-share.html.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.